ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000020

Surgery for levodopa-induced dyskinesias. Discussion

Identifieur interne : 000020 ( PascalFrancis/Curation ); précédent : 000019; suivant : 000021

Surgery for levodopa-induced dyskinesias. Discussion

Auteurs : A. E. Lang [Canada] ; LANGSTON ; RASCOL ; BROTCHIE ; BENABID ; MELAMED ; BONUCELLI ; OLANOW ; OBESO ; GIMENEZ-ROLDAN ; RAJPUT ; FAHN ; NUTT ; BROOKS ; CHASE

Source :

Annals of neurology [ 0364-5134 ] ; 2000.

RBID : Pascal:00-0262068

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Dyskinésie, Lévodopa, Antiparkinsonien, Chirurgie, Article synthèse, Traitement, Homme, Thalamotomie, Pallidum, Transplantation.
Wicri :
- topic : Chirurgie, Homme.

English descriptors

KwdEn :
- Antiparkinson agent, Dyskinesia, Human, Levodopa, Pallidum, Parkinson disease, Review, Surgery, Thalamotomy, Transplantation, Treatment.

Abstract

The effects of surgical interventions for levodopa-induced dyskinesias (LIDs) in Parkinson's disease are reviewed. Since the introduction of levodopa, thalamotomy has been reported to have variable effects on LIDs. Striking benefit has been demonstrated, and efficacy is probably dependent on the size and location of the lesion. However, it remains unclear whether it is an effective treatment for all types of LIDs. Currently, pallidotomy is probably the most reliable and effective surgical treatment for LIDs, and will continue to play an important role in its management until other treatments become more widely available. Deep brain stimulation is an extremely exciting mode of therapy, particularly in the subthalamic nucleus and the globus pallidus, and early results of its use in the treatment of LIDs are promising. The effects of cerebral transplantation, still an experimental technique, on LIDs are inconsistent and controversial, and there is little reliable evidence that gamma knife radiosurgery can be safely applied to parkinsonian patients for the treatment of LIDs.

A01	`01`	`1`		`@0 0364-5134`
A02	`01`			`@0 ANNED3`
A03		`1`		`@0 Ann. neurol.`
A05				`@2 47`
A06				`@2 4 @3 SUP1`
A08	`01`	`1`	`ENG`	`@1 Surgery for levodopa-induced dyskinesias. Discussion`
A09	`01`	`1`	`ENG`	`@1 Levodopa-induced dyskinesias`
A11	`01`	`1`		`@1 LANG (A. E.)`
A11	`02`	`1`		`@1 LANGSTON @9 comment.`
A11	`03`	`1`		`@1 RASCOL @9 comment.`
A11	`04`	`1`		`@1 BROTCHIE @9 comment.`
A11	`05`	`1`		`@1 BENABID @9 comment.`
A11	`06`	`1`		`@1 MELAMED @9 comment.`
A11	`07`	`1`		`@1 BONUCELLI @9 comment.`
A11	`08`	`1`		`@1 OLANOW @9 comment.`
A11	`09`	`1`		`@1 OBESO @9 comment.`
A11	`10`	`1`		`@1 GIMENEZ-ROLDAN @9 comment.`
A11	`11`	`1`		`@1 RAJPUT @9 comment.`
A11	`12`	`1`		`@1 FAHN @9 comment.`
A11	`13`	`1`		`@1 NUTT @9 comment.`
A11	`14`	`1`		`@1 BROOKS @9 comment.`
A11	`15`	`1`		`@1 CHASE @9 comment.`
A12	`01`	`1`		`@1 OLANOW (C. Warren) @9 ed.`
A14	`01`			`@1 Toronto Western Hospital, Morton & Gloria Shulman Movement Disorders Clinic; and the University of Toronto @2 Ontario @3 CAN @Z 1 aut.`
A15	`01`			`@1 Department of Neurology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Annenburg 14-94 @2 New York, NY 10029 @3 USA @Z 1 aut.`
A20				`@2 S193-S202`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 16555 @5 354000082146950220`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 53 ref.`
A47	`01`	`1`		`@0 00-0262068`
A60				`@1 P @3 AR @3 CT`
A61				`@0 A`
A64	`01`	`1`		`@0 Annals of neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The effects of surgical interventions for levodopa-induced dyskinesias (LIDs) in Parkinson's disease are reviewed. Since the introduction of levodopa, thalamotomy has been reported to have variable effects on LIDs. Striking benefit has been demonstrated, and efficacy is probably dependent on the size and location of the lesion. However, it remains unclear whether it is an effective treatment for all types of LIDs. Currently, pallidotomy is probably the most reliable and effective surgical treatment for LIDs, and will continue to play an important role in its management until other treatments become more widely available. Deep brain stimulation is an extremely exciting mode of therapy, particularly in the subthalamic nucleus and the globus pallidus, and early results of its use in the treatment of LIDs are promising. The effects of cerebral transplantation, still an experimental technique, on LIDs are inconsistent and controversial, and there is little reliable evidence that gamma knife radiosurgery can be safely applied to parkinsonian patients for the treatment of LIDs.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Dyskinésie @5 04`
C03	`02`	`X`	`ENG`	`@0 Dyskinesia @5 04`
C03	`02`	`X`	`SPA`	`@0 Disquinesia @5 04`
C03	`03`	`X`	`FRE`	`@0 Lévodopa @5 07`
C03	`03`	`X`	`ENG`	`@0 Levodopa @5 07`
C03	`03`	`X`	`SPA`	`@0 Levodopa @5 07`
C03	`04`	`X`	`FRE`	`@0 Antiparkinsonien @5 08`
C03	`04`	`X`	`ENG`	`@0 Antiparkinson agent @5 08`
C03	`04`	`X`	`SPA`	`@0 Antiparkinsoniano @5 08`
C03	`05`	`X`	`FRE`	`@0 Chirurgie @5 10`
C03	`05`	`X`	`ENG`	`@0 Surgery @5 10`
C03	`05`	`X`	`SPA`	`@0 Cirugía @5 10`
C03	`06`	`X`	`FRE`	`@0 Article synthèse @5 16`
C03	`06`	`X`	`ENG`	`@0 Review @5 16`
C03	`06`	`X`	`SPA`	`@0 Artículo síntesis @5 16`
C03	`07`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`07`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`07`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`08`	`X`	`FRE`	`@0 Homme @5 20`
C03	`08`	`X`	`ENG`	`@0 Human @5 20`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`09`	`X`	`FRE`	`@0 Thalamotomie @5 23`
C03	`09`	`X`	`ENG`	`@0 Thalamotomy @5 23`
C03	`09`	`X`	`SPA`	`@0 Talamotomía @5 23`
C03	`10`	`X`	`FRE`	`@0 Pallidum @5 24`
C03	`10`	`X`	`ENG`	`@0 Pallidum @5 24`
C03	`10`	`X`	`SPA`	`@0 Pallidum @5 24`
C03	`11`	`X`	`FRE`	`@0 Transplantation @5 35`
C03	`11`	`X`	`ENG`	`@0 Transplantation @5 35`
C03	`11`	`X`	`SPA`	`@0 Trasplantación @5 35`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Trouble neurologique @5 46`
C07	`06`	`X`	`ENG`	`@0 Neurological disorder @5 46`
C07	`06`	`X`	`SPA`	`@0 Trastorno neurológico @5 46`
C07	`07`	`X`	`FRE`	`@0 Mouvement involontaire @5 47`
C07	`07`	`X`	`ENG`	`@0 Involuntary movement @5 47`
C07	`07`	`X`	`SPA`	`@0 Movimiento involuntario @5 47`
N21				`@1 178`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D04

Links to Exploration step

Pascal:00-0262068

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Surgery for levodopa-induced dyskinesias. Discussion</title>
<author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Hospital, Morton & Gloria Shulman Movement Disorders Clinic; and the University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Langston" sort="Langston" uniqKey="Langston" last="Langston">LANGSTON</name>
</author>
<author><name sortKey="Rascol" sort="Rascol" uniqKey="Rascol" last="Rascol">RASCOL</name>
</author>
<author><name sortKey="Brotchie" sort="Brotchie" uniqKey="Brotchie" last="Brotchie">BROTCHIE</name>
</author>
<author><name sortKey="Benabid" sort="Benabid" uniqKey="Benabid" last="Benabid">BENABID</name>
</author>
<author><name sortKey="Melamed" sort="Melamed" uniqKey="Melamed" last="Melamed">MELAMED</name>
</author>
<author><name sortKey="Bonucelli" sort="Bonucelli" uniqKey="Bonucelli" last="Bonucelli">BONUCELLI</name>
</author>
<author><name sortKey="Olanow" sort="Olanow" uniqKey="Olanow" last="Olanow">OLANOW</name>
</author>
<author><name sortKey="Obeso" sort="Obeso" uniqKey="Obeso" last="Obeso">OBESO</name>
</author>
<author><name sortKey="Gimenez Roldan" sort="Gimenez Roldan" uniqKey="Gimenez Roldan" last="Gimenez-Roldan">GIMENEZ-ROLDAN</name>
</author>
<author><name sortKey="Rajput" sort="Rajput" uniqKey="Rajput" last="Rajput">RAJPUT</name>
</author>
<author><name sortKey="Fahn" sort="Fahn" uniqKey="Fahn" last="Fahn">FAHN</name>
</author>
<author><name sortKey="Nutt" sort="Nutt" uniqKey="Nutt" last="Nutt">NUTT</name>
</author>
<author><name sortKey="Brooks" sort="Brooks" uniqKey="Brooks" last="Brooks">BROOKS</name>
</author>
<author><name sortKey="Chase" sort="Chase" uniqKey="Chase" last="Chase">CHASE</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0262068</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0262068 INIST</idno>
<idno type="RBID">Pascal:00-0262068</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D04</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000020</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Surgery for levodopa-induced dyskinesias. Discussion</title>
<author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Hospital, Morton & Gloria Shulman Movement Disorders Clinic; and the University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Langston" sort="Langston" uniqKey="Langston" last="Langston">LANGSTON</name>
</author>
<author><name sortKey="Rascol" sort="Rascol" uniqKey="Rascol" last="Rascol">RASCOL</name>
</author>
<author><name sortKey="Brotchie" sort="Brotchie" uniqKey="Brotchie" last="Brotchie">BROTCHIE</name>
</author>
<author><name sortKey="Benabid" sort="Benabid" uniqKey="Benabid" last="Benabid">BENABID</name>
</author>
<author><name sortKey="Melamed" sort="Melamed" uniqKey="Melamed" last="Melamed">MELAMED</name>
</author>
<author><name sortKey="Bonucelli" sort="Bonucelli" uniqKey="Bonucelli" last="Bonucelli">BONUCELLI</name>
</author>
<author><name sortKey="Olanow" sort="Olanow" uniqKey="Olanow" last="Olanow">OLANOW</name>
</author>
<author><name sortKey="Obeso" sort="Obeso" uniqKey="Obeso" last="Obeso">OBESO</name>
</author>
<author><name sortKey="Gimenez Roldan" sort="Gimenez Roldan" uniqKey="Gimenez Roldan" last="Gimenez-Roldan">GIMENEZ-ROLDAN</name>
</author>
<author><name sortKey="Rajput" sort="Rajput" uniqKey="Rajput" last="Rajput">RAJPUT</name>
</author>
<author><name sortKey="Fahn" sort="Fahn" uniqKey="Fahn" last="Fahn">FAHN</name>
</author>
<author><name sortKey="Nutt" sort="Nutt" uniqKey="Nutt" last="Nutt">NUTT</name>
</author>
<author><name sortKey="Brooks" sort="Brooks" uniqKey="Brooks" last="Brooks">BROOKS</name>
</author>
<author><name sortKey="Chase" sort="Chase" uniqKey="Chase" last="Chase">CHASE</name>
</author>
</analytic>
<series><title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Dyskinesia</term>
<term>Human</term>
<term>Levodopa</term>
<term>Pallidum</term>
<term>Parkinson disease</term>
<term>Review</term>
<term>Surgery</term>
<term>Thalamotomy</term>
<term>Transplantation</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dyskinésie</term>
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Chirurgie</term>
<term>Article synthèse</term>
<term>Traitement</term>
<term>Homme</term>
<term>Thalamotomie</term>
<term>Pallidum</term>
<term>Transplantation</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Chirurgie</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effects of surgical interventions for levodopa-induced dyskinesias (LIDs) in Parkinson's disease are reviewed. Since the introduction of levodopa, thalamotomy has been reported to have variable effects on LIDs. Striking benefit has been demonstrated, and efficacy is probably dependent on the size and location of the lesion. However, it remains unclear whether it is an effective treatment for all types of LIDs. Currently, pallidotomy is probably the most reliable and effective surgical treatment for LIDs, and will continue to play an important role in its management until other treatments become more widely available. Deep brain stimulation is an extremely exciting mode of therapy, particularly in the subthalamic nucleus and the globus pallidus, and early results of its use in the treatment of LIDs are promising. The effects of cerebral transplantation, still an experimental technique, on LIDs are inconsistent and controversial, and there is little reliable evidence that gamma knife radiosurgery can be safely applied to parkinsonian patients for the treatment of LIDs.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0364-5134</s0>
</fA01>
<fA02 i1="01"><s0>ANNED3</s0>
</fA02>
<fA03 i2="1"><s0>Ann. neurol.</s0>
</fA03>
<fA05><s2>47</s2>
</fA05>
<fA06><s2>4</s2>
<s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Surgery for levodopa-induced dyskinesias. Discussion</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Levodopa-induced dyskinesias</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>LANG (A. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LANGSTON</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="03" i2="1"><s1>RASCOL</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="04" i2="1"><s1>BROTCHIE</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="05" i2="1"><s1>BENABID</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="06" i2="1"><s1>MELAMED</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="07" i2="1"><s1>BONUCELLI</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="08" i2="1"><s1>OLANOW</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="09" i2="1"><s1>OBESO</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="10" i2="1"><s1>GIMENEZ-ROLDAN</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="11" i2="1"><s1>RAJPUT</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="12" i2="1"><s1>FAHN</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="13" i2="1"><s1>NUTT</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="14" i2="1"><s1>BROOKS</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="15" i2="1"><s1>CHASE</s1>
<s9>comment.</s9>
</fA11>
<fA12 i1="01" i2="1"><s1>OLANOW (C. Warren)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Toronto Western Hospital, Morton & Gloria Shulman Movement Disorders Clinic; and the University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Neurology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Annenburg 14-94</s1>
<s2>New York, NY 10029</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA20><s2>S193-S202</s2>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>16555</s2>
<s5>354000082146950220</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>53 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0262068</s0>
</fA47>
<fA60><s1>P</s1>
<s3>AR</s3>
<s3>CT</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The effects of surgical interventions for levodopa-induced dyskinesias (LIDs) in Parkinson's disease are reviewed. Since the introduction of levodopa, thalamotomy has been reported to have variable effects on LIDs. Striking benefit has been demonstrated, and efficacy is probably dependent on the size and location of the lesion. However, it remains unclear whether it is an effective treatment for all types of LIDs. Currently, pallidotomy is probably the most reliable and effective surgical treatment for LIDs, and will continue to play an important role in its management until other treatments become more widely available. Deep brain stimulation is an extremely exciting mode of therapy, particularly in the subthalamic nucleus and the globus pallidus, and early results of its use in the treatment of LIDs are promising. The effects of cerebral transplantation, still an experimental technique, on LIDs are inconsistent and controversial, and there is little reliable evidence that gamma knife radiosurgery can be safely applied to parkinsonian patients for the treatment of LIDs.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lévodopa</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Levodopa</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Levodopa</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Surgery</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Review</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Thalamotomie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Thalamotomy</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Talamotomía</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Pallidum</s0>
<s5>24</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Pallidum</s0>
<s5>24</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Pallidum</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Transplantation</s0>
<s5>35</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Transplantation</s0>
<s5>35</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Trasplantación</s0>
<s5>35</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>47</s5>
</fC07>
<fN21><s1>178</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000020 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000020 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0262068
   |texte=   Surgery for levodopa-induced dyskinesias. Discussion
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Surgery for levodopa-induced dyskinesias. Discussion

Surgery for levodopa-induced dyskinesias. Discussion

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri